EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
-1.38%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$843M
AUM Growth
+$843M
(-18%)
Cap. Flow
-$112M
Cap. Flow
% of AUM
-13.23%
Top 10 Holdings %
Top 10 Hldgs %
64.12%
Holding
79
New
8
Increased
25
Reduced
24
Closed
13
Top Buys
| 1 |
Natera
NTRA
|
$41.6M |
| 2 |
GSK
GSK
|
$39.9M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$23.5M |
| 4 |
Illumina
ILMN
|
$13.7M |
| 5 |
Seres Therapeutics
MCRB
|
$12.4M |
Top Sells
| 1 |
AstraZeneca
AZN
|
$67.4M |
| 2 |
Avantor
AVTR
|
$20.5M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
$20.3M |
| 4 |
argenx
ARGX
|
$16.1M |
| 5 |
Tandem Diabetes Care
TNDM
|
$15.2M |
Sector Composition
| 1 | Healthcare | 98.6% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RCM
76
DELISTED
R1 RCM Inc. Common Stock
RCM
| – | – |
-590,819
| Closed | -$12.4M |
|
|
SWAV
77
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| – | – |
-3,300
| Closed | -$631K |
|
|
RDUS
78
DELISTED
Radius Health, Inc.
RDUS
| – | – |
-502,587
| Closed | -$5.21M |
|
79
ARK Innovation ETF
ARKK
$7.49B
| – | – |
0
| – | – |
|